SYNERGENETICS BIOSCIENCE
SynerGenetics Bioscience Inc. is a Canadian plant genetics research and development company focused on developing high-yield CBD hemp strains/seeds. The Company is led by a management team with combined 35+ years of cannabis/hemp industry experience and a clear vision of capitalizing on the growing hemp and CBD markets. SG’s R&D team successfully utilized proprietary technology to identify desirable plant traits to create hemp strains yielding 12%+ CBD content to address commercial hemp farming problems. With yields averaging less than 7% on many strains used by hemp farmers, the 5% difference is material – both financially and quality wise.
SYNERGENETICS BIOSCIENCE
Social Links:
Industry:
Biotechnology Genetics Product Research
Founded:
2019-01-01
Address:
Vancouver, British Columbia, Canada
Country:
Canada
Website Url:
http://www.sgbioscience.com
Total Employee:
1+
Status:
Active
Contact:
+1 604 249 2143
Email Addresses:
[email protected]
Total Funding:
6 M USD
Technology used in webpage:
SPF Organization Schema Google Apps For Business GoDaddy DNS Squarespace Hosted
Similar Organizations
Abogen Biosciences
Abogen Biosciences is a discovery stage biotechnology company focuses on developing nucleic acid-based RNA and DNA therapeutics.
iECURE
iECURE is a mutation-agnostic in vivo gene editing company striving to cure devastating diseases with high unmet needs.
METiS Therapeutics
METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.
Current Employees Featured
Founder
Official Site Inspections
http://www.sgbioscience.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "SynerGenetics Bioscience"
SK bioscience ESG
Www.skbioscience.com: No. of Employees: 1,101: Financial Performance 1) Revenue : KRW 369.5 billion; Operating Loss : KRW 12 billion; ... the world's second WHO PQ certification and …See details»
SK bioscience
Conducting research into vaccines that will be the driving force in the life science business going forward.See details»
SK bioscience ESG
(Former) Visiting Scholar, Organization and Management Theory Division, Northwestern University (Former) Assistant Professor of Management and Organization, Marshall School of …See details»
SK bioscience
Refers to the attitude of knowing one's work, setting challenging goals, executing them thoroughly with passion, and transferring a knowledge within the organization. "Warm Professional" refers to employees of SK bioscience who …See details»
SK bioscience
Signed agreement with international organization PATH to develop and produce pediatric enteritis vaccine for developing countries; 2018. SKYVaricella Inj. licensed to market, Korea’s second …See details»
SK bioscience ESG
SK bioscience diagnoses the current level of happiness among our employees by conducting SK Culture Survey and Good Life Lab Happiness Diagnosis. Also we strengthens internal …See details»
SK Bioscience - Crunchbase Investor Profile
SK Bioscience is a vaccine development company that invests and builds infrastructure for continuous vaccine development .See details»
SK bioscience - Company Profile & Staff Directory - ContactOut
At SK bioscience, we work everyday to promote human health from prevetion to cure. We have successfully developed South Korea's first COVID-19 vaccine, 'SKYCovione' through global …See details»
SK Bioscience - Overview, News & Similar companies - ZoomInfo
SK bioscience COVID-19 Vaccine Granted Emergency Use Listing by the World Health Organization SEONGNAM, South Korea, June 19, 2023 /PRNewswire/ -- SK bioscience, a …See details»
SK Bioscience - Devex
Learn more about SK Bioscience's jobs, projects, latest news, contact information and geographical presence. R&D Goal The domestic vaccine market is worth KRW 700 billion (as …See details»
Our ESG - SK bioscience
We extend our deepest gratitude to everyone who has consistently encouraged and supported SK bioscience’s continuous growth. Since the publication of our first ESG report in 2022, SK bioscience has achieved significant milestones, …See details»
SK Bioscience - Craft
See insights on SK Bioscience including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
SK bioscience- Government Pharmaceutical Organization Sign …
Jul 5, 2023 Government Pharmaceutical Organization 75/1 Rama VI Road, Thung Prayathai, Rajthevi, Bangkok 10400 Tel. 02-203-8000, 02-354-8780 Call Center 1648 …See details»
History - SK bioscience
Granted Emergency Use Listing by the World Health Organization (SKYCovione™) Signed a research collaboration agreement on influenza research with the Doherty Institute; Announced …See details»
SK bioscience ESG
As a partner organization of the World Health Organization(WHO), SK bioscience is dedicated to nurturing the next generation of bio-talent through providing education and on-site visits. In …See details»
SK bioscience ESG
Collaborating with a third-party organization, we ensured objectivity in risk determination and identified actual and potential human rights risks through the human rights impact assessment …See details»
Press releases - SK bioscience
May 23, 2023 Under the title ‘National and Regional Health Security from mRNA to a Sustainable Regional Manufacturing Framework,’ representatives of international …See details»
SK bioscience COVID-19 Vaccine Granted Emergency Use Listing …
SEONGNAM, South Korea, June 19, 2023 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health from prevention to cure, …See details»
Press releases - SK bioscience
Jun 27, 2024 IDT Biologika is recognized for its strong business capabilities by wining in all of six categories at the 2024 CDMO Leadership Awards, hosted by Life Science Leader, a U.S. …See details»
Press releases - SK bioscience
SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entered into a development …See details»